Source: Business Wire

Press Release: Gene Signal : Corneal Neovascularization - Global Clinical Trials Review, H2, 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Corneal Neovascularization Global Clinical Trials Review, H2, 2017" clinical trials has been added to Research and Markets' offering. The clinical trial report, Corneal Neovascularization Global Clinical Trials Review, H2, 2017, provides an overview of Corneal Neovascularization clinical trials scenario. This report provides top line data relating to the clinical trials on Corneal Neovascularization. Report includes an overview of trial numbers and their average en

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Eric Viaud's photo - Co-Founder & CEO of Gene Signal

Co-Founder & CEO

Eric Viaud

CEO Approval Rating

81/100

Read more